
Robotic lobectomies grew from 49% to 70% of cases from 2020 to 2024 as access and training expanded, says Staci Beamer, M.D., of HonorHealth.
New treatment approaches could lead to even higher costs associated with lymphoma. However, experts say these treatments hold great promise and could reduce costs in the long-term.






